Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.630
+0.080 (5.16%)
Apr 14, 2026, 4:00 PM EDT - Market closed
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $45.7 million as of April 15, 2026. Its market cap has increased by 19.33% in one year.
Market Cap
45.70M
Enterprise Value
42.49M
1-Year Change
19.33%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $45.70M, a decrease of -71.24%. That is a compound annual growth rate of -13.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 43.50M | 42.62% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 46.13M |
| RenovoRx | 45.95M |
| Atossa Therapeutics | 45.73M |
| Lisata Therapeutics | 45.07M |
| Telomir Pharmaceuticals | 44.70M |
| Werewolf Therapeutics | 44.59M |
| Rallybio | 43.90M |
| NextCure | 43.86M |